Evidence map›Paper›PMID 38938341›Full record

ArticleJACC. Advances2023

Cardiometabolic Risk Factors in Mexican Adults With Congenital Heart Disease.

Edgar García-Cruz, Daniel Manzur-Sandoval, Rodrigo Gopar-Nieto, Juan C Plata-Corona, Isis G Montalvo-Ocotoxtle, Daniel Alejandro Navarro-Martinez, Elisa Mier Y Terán-Morales, Frida Rivera-Buendía, Neftali Eduardo Antonio-Villa, Naybeth E García-González and 12 more

Abstract read
In one paragraph

Article in JACC. Advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Edgar García-CruzCongenital Heart Disease Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Daniel Manzur-SandovalCardiovascular Critical Care Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Rodrigo Gopar-NietoCoronary Care Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Juan C Plata-CoronaCardiology Fellowship, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Isis G Montalvo-OcotoxtleEndocrinology Department, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Daniel Alejandro Navarro-MartinezDepartment of Cardiothoracic and Vascular Surgery, University of Texas Health Science Center, Houston, Texas, USA.
Elisa Mier Y Terán-MoralesEndocrinology Department, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Frida Rivera-BuendíaResearch Department, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Neftali Eduardo Antonio-VillaEndocrinology Department, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Naybeth E García-GonzálezCongenital Heart Disease Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Stephanie T Angulo-CruzadoCongenital Heart Disease Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Sheila V Sánchez-LópezCongenital Heart Disease Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
José M Torres-MartelCongenital Heart Disease Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Linda G Díaz-GallardoCongenital Heart Disease Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Axel J Barrera-RealEndocrinology Department, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Víctor A Quiroz-MartínezCongenital Heart Disease Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Montserrat Villalobos PedrozaCardiology Fellowship, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Jorge Sánchez-NietoCardiology Fellowship, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Miriam Valdez-RamosCongenital Heart Disease Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Nydia Ávila-VanzziniGeneral Cardiology Outpatient Clinic, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Juan M Vera-ZertucheEndocrinology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico City, Mexico.
Francisco M Baranda-TovarSurgical and Medical Specialties Direction, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In recent decades, adults living with congenital heart disease (ACHD) have improved their survival, thus increasing their predisposition to the onset of cardiometabolic risk factors and chronic health conditions. Objectives: The purpose of this study was to describe cardiometabolic risk profiles in the ACHD population and their relationship to congenital heart disease (CHD) lesion complexity. Methods: We performed a cross-sectional study from ACHD in a third-tier referral center in Mexico City. The association between cardiometabolic risk factors and CHD complexity was estimated using logistic regression models. Results: Our study cohort included 1,171 ACHD patients (median age: 31 [IQR: 23.2-42.7] years, male 63.6%). Cardiac diagnosis was classified as mild (44.9%), moderate (37.8%), and severe (17.2%) CHD complexity. Low high-density lipoprotein cholesterol (55%) was the most common cardiometabolic risk factor; followed by insulin resistance (54.5%) and prediabetes (52.4%). Patients with mild and moderate CHD had a higher prevalence of obesity and metabolic syndrome, while patients with severe CHD had a higher prevalence of hyperuricemia and subclinical hypothyroidism. In the logistic regression analysis, the severity of CHD was associated with higher odds of hyperuricemia (moderate CHD, OR: 1.87; 95% CI: 1.20-2.93; Conclusions: We observed high rates of cardiometabolic risk factors in Mexican ACHD patients and these risk profiles varied by CHD lesion complexity. These results highlight the need for ongoing metabolic health surveillance in the ACHD population.

Indexed as

adult congenital heart diseasecardiometabolic risk factorshyperuricemiainsulin resistancetype 2 diabetes

Identifiers

PMID38938341
PMCPMC11198451

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.